论文信息 - The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer - 字舞流文

The management impact of 68gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (68Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer

P. Dasgupta | R. Popert | S. Morris | S. Hughes | A. Mallia | G. Cook | V. Warbey | A. Aggarwal | Christian Brown | V. Gibson | B. Challacombe | P. Cathcart | Jennifer D. Young | M. Kulkarni